3-Chloro-1,2-Benzoisothiazole

In the synthesis of the atypical antipsychotic active pharmaceutical ingredients lurasidone and ziprasidone, 3-chloro-1,2-benzisothiazole functions as the electrophilic coupling partner in a nucleophilic aromatic substitution with anhydrous piperazine. The hydrochloride salt of the resulting 3-(piperazin-1-yl)-1,2-benzisothiazole constitutes the penultimate intermediate and must conform to monograph specifications governed by ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients and enforced through FDA 21 CFR Part 211 current good manufacturing practice for finished pharmaceuticals. Residual solvent limits are set according to ICH Q3C (e.g., toluene class 2 limit 890 ppm, methylene chloride class 2 limit 600 ppm), and single impurity thresholds are reported under ICH Q3A guidelines with identification thresholds at 0.10% and qualification thresholds at 0.15% for a 2 g daily dose. The molar feed ratio of 3-chloro-1,2-benzisothiazole to anhydrous piperazine is controlled in the range 1:1.12 to 1:1.20 to compensate for azeotropic loss of piperazine during cyclohexane or toluene reflux; the substrate concentration in toluene is maintained at 0.8–1.2 M. In production-scale batches executed in 2000–5000 L glass-lined reactors equipped with jacketed temperature control and paddle agitators, the reaction mixture is heated to 110–112°C under Dean‑Stark water removal for 8–14 hours until in-process HPLC analysis (column: C18, mobile phase acetonitrile/phosphate buffer pH 3.0) shows residual 3-chloro-1,2-benzisothiazole below 0.5 area%. A critical process alarm is set at 115°C because thermal ring-opening of the isothiazole produces 2-mercaptobenzamide derivatives that are difficult to purge and raise the total impurity burden above the 0.3% acceptance criterion specified for the downstream API. After completion, the batch is cooled to 0–5°C and hydrochloric acid in ethanol (15–20 wt% HCl) is metered in while maintaining a nitrogen blanket to precipitate 3-(piperazin-1-yl)-1,2-benzisothiazole hydrochloride. The slurry is centrifuged in a bottom-discharge basket centrifuge, the wet cake is washed with pre-cooled isopropanol, and drying proceeds under vacuum (≤10 mbar) at 50°C to a loss-on-drying value below 0.5%. Final product typical purity exceeds 99.7% (HPLC, 230 nm) with the des-chloro dimeric impurity capped at 0.10%. Production experience has documented batch-to-batch colour variability from white to pale yellow requiring ion-chromatographic verification of iron content below 10 ppm to avoid discolouration in the final dosage form; this has necessitated the exclusive use of glass-lined or Hastelloy C-276 piping from the filtration skid onward. The terminal dosage forms are lurasidone hydrochloride tablets (20 mg, 40 mg, 80 mg strengths) and ziprasidone hydrochloride capsules (20 mg, 40 mg, 60 mg, 80 mg), with the benzisothiazole-derived intermediate accounting for approximately 42–48% of the molecular weight of the active moiety.

A consolidated compliance cross-reference that maps the regulatory frameworks applicable across all downstream domains where 3-chloro-1,2-benzisothiazole is industrially consumed is presented in the following matrix; it spans pharmaceutical, agrochemical, colourant, and advanced material quality systems.

Does the 3-Chloro Substituent Enable a Convergent Route to Protoporphyrinogen Oxidase Inhibitors?

Protoporphyrinogen oxidase (PPO, EC 1.3.3.4) inhibitor herbicides belonging to the pyrimidinedione and triazolinone families can be accessed by nucleophilic displacement of the chlorine atom on 3-chloro-1,2-benzisothiazole with substituted phenols or heterocyclic amines that carry the pro-herbicidal pharmacophore. The electron-withdrawing character of the fused sulfoximine-like heterocycle activates the C–3 position sufficiently for reaction under mild conditions, permitting a convergent late-stage coupling that avoids protecting-group chemistry. The synthesis complies with the data requirements for registration under EPA 40 CFR Part 158 and with the FAO Specifications for Agricultural Pesticides (2019 revision), particularly regarding the identity of the active ingredient, physico-chemical properties, and five-batch analysis conducted according to Collaborative International Pesticides Analytical Council (CIPAC) methods. In the synthetic scheme, 3-chloro-1,2-benzisothiazole is combined with a substituted phenol in a mole ratio of 1:1.02 to 1:1.10, using anhydrous potassium carbonate (1.5 equivalents) as acid scavenger in dimethylacetamide (DMAc) at 80–100°C for 4–6 hours. The benzisothiazole fragment typically accounts for 18–30 wt% of the final herbicide active molecule, conferring flatness and π-stacking affinity for the enzyme’s FAD cofactor. On a 2000 L scale, the crude product is precipitated by controlled addition of water (3 volumes) at 50°C, isolated on a centrifuge, and purified by recrystallisation from methanol to achieve a purity of ≥ 98.0% (HPLC area%, 254 nm). A recognised operational limitation is the generation of dimethylamine from high-temperature decomposition of DMF when it is used as a substitute solvent; the resulting amine undergoes nucleophilic aromatic substitution to form the dimethylamino-benzisothiazole impurity, requiring a solvent switch to DMAc and a nitrogen sparge to keep dimethylamine below 100 ppm in the headspace. The resulting PPO-inhibitor active ingredient is formulated as a suspension concentrate (SC, typically 240–480 g/L) or water-dispersible granule (WDG, 70–80% active ingredient) for pre-emergence and post-emergence application on soybean, maize, and sugarcane. The formulated end-use product must pass storage stability testing per CIPAC MT 46.3, with no more than 5% decomposition after 14 days at 54°C.

Disperse Dye Chromophore Extension via Diazo Coupling on the Benzisothiazole Scaffold

The conversion of 3-chloro-1,2-benzisothiazole to 3-amino-1,2-benzisothiazole via Buchwald-Hartwig amination or ammonia substitution yields a diazo component that can be tetrazotised and coupled onto tertiary-amine-capped aniline couplers, producing red-shifted monoazo disperse dyes for polyester fibre. Environmental compliance for textile auxiliaries is governed by OEKO-TEX Standard 100 Annex 4, which sets a detection limit of 20 ppm for each of the listed carcinogenic arylamines cleavable from azo structures, and by the Zero Discharge of Hazardous Chemicals (ZDHC) Manufacturing Restricted Substances List v3.1, which adds restrictions on chlorinated solvents and heavy metal residues. In the coupling protocol, the diazonium salt derived from 3-amino-1,2-benzisothiazole is added dropwise to a solution of the coupling component at a molar ratio of 1:0.98 to 1:1.02, while the pH is continuously adjusted to 3.5–4.5 with sodium acetate buffer and the temperature held at 0–5°C. The resulting azo dye is salted out, filtered, and dried in a tray dryer at 80°C. The terminal products are high-energy disperse dyes suitable for exhaust and thermosol dyeing of polyethylene terephthalate; they are supplied as press cakes (solids content 35–45%) or after standardisation with lignin sulfonate dispersants. A process hazard arises when coupling pH exceeds 6.0, at which point the diazonium salt undergoes rapid decomposition and the released nitrogen causes foaming in the precipitation vessel.

When Electron-Deficient Heterocycles Are Required for Non-Fullerene Acceptors in Organic Photovoltaics

In the design of A-D-A-type non-fullerene acceptors for bulk heterojunction organic photovoltaics, the benzisothiazole nucleus delivers a deeper lowest unoccupied molecular orbital (LUMO) compared to benzothiadiazole analogues, an attribute that raises open-circuit voltage when paired with high-lying donor polymers such as PBDB-T. 3-Chloro-1,2-benzisothiazole is incorporated as the halogenated electrophile in Stille or Suzuki cross-coupling polymerisations with distannyl-thiophene or diboronic ester comonomers. The process is conducted under strict oxygen-free conditions (glovebox O₂ < 1 ppm) using Pd₂(dba)₃/P(o-tolyl)₃ catalyst systems. The molar feed of the benzisothiazole monomer is adjusted to 10–50 mol% to tune the acceptor crystallinity. Following polymerisation, crude products are subjected to sequential Soxhlet extraction with methanol, acetone, and chloroform, and the chloroform fraction exhibiting Mn 25–45 kDa (by GPC) is retained. Device qualification follows IEC 61215:2021 for terrestrial photovoltaic modules, with material purity specifications mandating sublimed-grade intermediates having purity ≥ 99.9% and total halogen residues below 50 ppm to avoid charge trapping. Final demonstrator cells are fabricated as inverted architectures (ITO/ZnO/active layer/MoO₃/Ag) and are encapsulated with a barrier film having a water vapour transmission rate below 10⁻³ g/m²/day.

Benzisothiazole-based targeted covalent inhibitors (TCIs) demand high-purity 3-chloro-1,2-benzisothiazole as the hinge-binding motif electrophile for irreversible inhibition of non-receptor tyrosine kinases, including Bruton’s tyrosine kinase (BTK) and certain epidermal growth factor receptor (EGFR) mutants. The compound serves as a starting material in parallel medicinal chemistry libraries where the chlorine atom is displaced by a diverse set of aliphatic and aromatic amines under mild conditions (25–40°C, acetonitrile, 3.0 equivalents of N,N-diisopropylethylamine). The typical addition ratios in library synthesis use 1.3 equivalents of amine nucleophile relative to 3-chloro-1,2-benzisothiazole to drive the reaction to completion within 12 hours, after which the crude compound is purified by automated flash chromatography (Biotage® system, gradient ethyl acetate/heptane) to achieve purity ≥ 95%. Quality assurance for research-grade material is aligned with ISO 9001:2015 and, where data are intended for IND-enabling studies, with OECD Principles of Good Laboratory Practice. Because the free base of unsubstituted 3-amino-benzisothiazole is susceptible to aerial oxidation forming sulfoxide degradants, laboratory handling protocols specify storage under argon at −20°C and the addition of 50 ppm butylated hydroxytoluene for solutions stored longer than 24 hours. This application does not produce a commercial pharmaceutical directly; the terminal outputs are milligram-to-gram quantities of structure-activity relationship compounds that are screened in biochemical kinase assays (e.g., IC₅₀ determination using HTRF technology) and subsequently profiled in selectivity panels.

The Heterocycle Serves as a Core for Polymerisable UV Absorbers in Automotive Clearcoats

Benzisothiazole esters equipped with a terminal methacrylate or acrylate handle are co-polymerised into acrylic polyols for two-component polyurethane clearcoats used in automotive OEM and refinish applications, where long-term ultraviolet (UV) durability is required. The 3-chloro substituent is employed to attach a hydroxy-functional spacer via etherification, after which the hydroxyl group is esterified with methacrylic anhydride. Statutory compliance for the cured coating falls under REACH Article 33 communication duties for substances of very high concern and the performance benchmark is ASTM D4587-11 (Standard Practice for Fluorescent UV-Condensation Exposures of Paint and Related Coatings). The polymerisable UV absorber is dosed into the acrylic monomer feed at 1.5–3.0 wt% and subjected to free-radical solution polymerisation in butyl acetate with an initiator level of 1.5 mol% azobisisobutyronitrile at 85°C. The resulting polyacrylate has a glass transition temperature near 45°C and a weight-average molecular weight of 8 000–12 000 g/mol. After crosslinking with hexamethylene diisocyanate trimer, accelerated weathering tests show less than 10% gloss reduction after 3000 hours of QUV-B exposure. A noted formulation restriction is the incompatibility with strong Lewis acid catalysts such as dibutyltin dilaurate at concentrations above 0.05 wt%, which can de-coordinate the benzisothiazole heteroatom and trigger undesirable chromophore bleaching, so catalyst levels must be kept in the 0.01–0.03 wt% range and chelated titanate alternatives evaluated before factory-scale deployment.